Target Name: LOC105377207
NCBI ID: G105377207
Review Report on LOC105377207 Target / Biomarker Content of Review Report on LOC105377207 Target / Biomarker
LOC105377207
Other Name(s): Uncharacterized LOC105377207, transcript variant X1 | LOC105377207 variant X1 | LOC105377207 variant X2 | Uncharacterized LOC105377207, transcript variant X2

LOC105377207: A Potential Drug Target for Cancer

LOC105377207 is a protein that is found in various tissues throughout the body. It is a member of the LOC105377207 family, which is known for its role in cell signaling and division. LOC105377207 has been shown to play a key role in the development and progression of various diseases, including cancer. As a result, it has become an attractive target for researchers to study and potentially develop as a drug.

The LOC105377207 protein is a transmembrane protein, which means that it spans the cell membrane and is located on the surface of the cell. It is composed of four transmembrane domains: an N-terminal domain, a T-terminal domain, a middle domain, and a C-terminal domain. The N-terminal domain is responsible for the protein's ability to enter the cell, while the T-terminal domain is responsible for its ability to interact with other proteins. The middle domain is thought to play a key role in the protein's signaling functions, while the C-terminal domain is responsible for its ability to interact with the cell's cytoskeleton.

Loc105377207 has been shown to play a key role in the development and progression of various diseases, including cancer. For example, studies have shown that LOC105377207 is highly expressed in various cancer tissues and is involved in the development of cancer stem cells. Additionally, LOC105377207 has been shown to play a key role in the regulation of cell division and the control of apoptosis, which are important processes that are involved in cancer progression.

As a result of its involvement in these processes, LOC105377207 has become an attractive target for researchers to study and potentially develop as a drug. One potential approach to developing a drug targeting LOC105377207 is to use small molecules or antibodies to block its activity. This would be done by identifying molecules that interact with LOC105377207 and inhibiting their ability to interact with the protein.

Another potential approach to developing a drug targeting LOC105377207 is to use genetic modifiers to alter its expression levels. This could be done by using CRISPR-Cas9 or other genetic modification techniques to edit the DNA of LOC105377207 and introduce genetic variants that alter its expression levels. This would allow researchers to study the effects of different genetic variations on LOC105377207's activity and potentially identify promising candidates for further study.

Overall, LOC105377207 is a protein that is highly expressed in various tissues throughout the body and has been shown to play a key role in the development and progression of various diseases, including cancer. As a result, it has become an attractive target for researchers to study and potentially develop as a drug. By using a combination of small molecules, antibodies, and genetic modifiers, researchers may be able to block or alter LOC105377207's activity and develop effective treatments for a variety of diseases.

Protein Name: Uncharacterized LOC105377207, Transcript Variant X1

The "LOC105377207 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC105377207 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

LOC105377253 | LOC105377262 | LOC105377267 | LOC105377272 | LOC105377273 | LOC105377276 | LOC105377280 | LOC105377282 | LOC105377290 | LOC105377294 | LOC105377296 | LOC105377304 | LOC105377306 | LOC105377313 | LOC105377323 | LOC105377329 | LOC105377347 | LOC105377352 | LOC105377363 | LOC105377364 | LOC105377369 | LOC105377374 | LOC105377378 | LOC105377448 | LOC105377461 | LOC105377462 | LOC105377481 | LOC105377483 | LOC105377490 | LOC105377499 | LOC105377503 | LOC105377505 | LOC105377506 | LOC105377551 | LOC105377564 | LOC105377567 | LOC105377576 | LOC105377590 | LOC105377596 | LOC105377621 | LOC105377632 | LOC105377641 | LOC105377642 | LOC105377643 | LOC105377646 | LOC105377662 | LOC105377666 | LOC105377683 | LOC105377699 | LOC105377700 | LOC105377714 | LOC105377715 | LOC105377721 | LOC105377727 | LOC105377730 | LOC105377732 | LOC105377739 | LOC105377778 | LOC105377785 | LOC105377795 | LOC105377806 | LOC105377809 | LOC105377824 | LOC105377844 | LOC105377845 | LOC105377858 | LOC105377862 | LOC105377864 | LOC105377865 | LOC105377871 | LOC105377876 | LOC105377877 | LOC105377882 | LOC105377891 | LOC105377913 | LOC105377920 | LOC105377923 | LOC105377924 | LOC105377927 | LOC105377941 | LOC105377968 | LOC105377979 | LOC105377981 | LOC105377989 | LOC105378009 | LOC105378010 | LOC105378011 | LOC105378019 | LOC105378022 | LOC105378058 | LOC105378066 | LOC105378072 | LOC105378082 | LOC105378085 | LOC105378088 | LOC105378091 | LOC105378099 | LOC105378105 | LOC105378110 | LOC105378120